China

Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29

Share

Share - WeChat

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo

US students gain deeper understanding of Confucius in Qufu

Road reinforcement underway at core mudslide-affected zone

Rongcheng fishing ports busy sorting catches after summer ban ends

Rescue ops intensified as road access to Gyirong Port basically restored

Rescue, relief efforts underway in typhoon-hit Minhou county, China's Fujian

Mobile food truck serves hot meals to rescuers in mudslide-hit Gyirong

Latest

State Council News

Policies concerning expats, foreign enterprises in August 2026

Exclusive

Hands off! Do robots do it all by themselves?

Middle school students teach humanoid robots to dance!

Taking robot show to the next level

Newsmaker

Hunan runner makes history at North Pole marathon

Student gets second home in Beijing

Special Coverage

105th founding anniv. of the CPC

75th anniv. of Xizang's peaceful liberation

BACK TO THE TOP

English

中文

Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

About China Daily

Advertise on Site

Expat Employment

FOLLOW US